Gypenoside LXXV
Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect[1].
Product Specifications
CAS Number
110261-98-8
UNSPSC
12352005
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gypenoside-lxxv.html
Purity
98.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@]([C@@]([C@@]1([H])[C@@]2([H])[C@@](CC/C=C(C)/C)(C)O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@H]3O)CO[C@@H]([C@@H]([C@H]4O)O)O[C@@H]([C@H]4O)CO)(CC2)C)(CC[C@@]5([H])C6(C)C)[C@@](C[C@H]1O)([H])[C@]5(CC[C@@H]6O)C
Molecular Formula
C42H72O13
Molecular Weight
785.01
References & Citations
[1]Chang-Hao Cui, et al. Enhanced Production of Gypenoside LXXV Using a Novel Ginsenoside-Transforming β-Glucosidase from Ginseng-Cultivating Soil Bacteria and Its Anti-Cancer Property. Molecules. 2017 May 19;22 (5) :844.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740257-100 1x 100 µL
Cytokeratin, HMW (AE-3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472808-500 1x 500 µL
Cytokeratin 18 (KRT18) (KRT18/2808R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401867-100 1x 100 µL
CD8A (Cytotoxic-&Suppressor T-Cell Marker) (rC8/468), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details